10 Years of T Cell Research in Rheumatoid Arthritis Mapped in 7,037 Papers
A bibliometric analysis of 7,037 studies reveals gut microbiota, fibroblast-like synoviocytes, and biologic therapy as the emerging frontiers in RA immunology.
Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
330 articles
A bibliometric analysis of 7,037 studies reveals gut microbiota, fibroblast-like synoviocytes, and biologic therapy as the emerging frontiers in RA immunology.
A pilot study finds one 30-minute PAPIMI electromagnetic field session significantly reduced pain scores and raised parasympathetic HRV markers in chronic musculoskeletal pain patients.
New review shows precision biomarkers and biologic drugs are transforming how clinicians select and treat children with persistent cow's milk allergy.
New biomarker in joint tissue correlates with inflammation severity and may explain why some patients don't respond to corticosteroids.
Specialized immune cells use antibodies to kill hepatitis B-infected cells, offering new targets for viral cure strategies.
Breakthrough immunotherapy approach demonstrates effectiveness in treating multiple autoimmune conditions simultaneously.
Groundbreaking study reveals how B cells acquire mutations in checkpoint genes to bypass immune tolerance in autoimmune thyroid disease.
Medical imaging reveals intraosseous abscess formation in patient with subacute osteomyelitis, highlighting diagnostic challenges.
International study of 1,200+ patients identifies clinical factors that predict sight-threatening complications in uveitis.
JAMA study reveals promising approach to prevent respiratory syncytial virus hospitalizations in vulnerable newborns.
New research reveals how hepatitis B virus hijacks cellular machinery to suppress interferon signaling and evade immune detection.
New research reveals how fat tissue activates T cells, potentially explaining the link between obesity and inflammatory joint disease.